Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| G1 Therapeutics, Inc. | 4,075,211 | reported | 30 Nov 2017 | tx 2+995−99,513 |
| MAXYGEN INC | 64,000 | reported | 06 Jun 2012 | tx 8+98,314 |
| BIOCRYST PHARMACEUTICALS INC | 39,072 | reported | 13 Jun 2023 | tx 24+439,539−71,582 |
| HYPERION DEFI, INC. | 30,769 | reported | 16 Jun 2022 | tx 14+128,308 |
| Aralez Pharmaceuticals Inc. | 15,000 | reported | 11 May 2017 | tx 10+131,073−1,404 |
| PhaseBio Pharmaceuticals Inc | 0 | reported | 22 Oct 2018 | tx 37+2,572,022−2,274,759 |
| ABGENIX INC | 0 | reported | 01 Apr 2006 | tx 4+15,000−75,000 |
| CV THERAPEUTICS INC | 0 | reported | 14 Apr 2009 | tx 23+101,250−105,155 |
| INSPIRE PHARMACEUTICALS INC | 0 | reported | 13 May 2011 | tx 44+225,555−240,622 |
| POZEN INC /NC | 0 | reported | 23 Jun 2015 | tx 41+204,850−174,663 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Jun 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 16,745 | 0.00 USD | |
| 13 Jun 2023 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 39,072 | 0.00 USD | deriv |
| 31 Jan 2023 | EXERCISE | BIOCRYST PHARMACEUTICALS INC | 15,000 | 1.71 USD | |
| 31 Jan 2023 | EXERCISE | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | HYPERION DEFI, INC. | 22,222 | 0.00 USD | |
| 16 Jun 2022 | GRANT_AWARD | HYPERION DEFI, INC. | 30,769 | 0.00 USD | deriv |
| 07 Jun 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 12,866 | 0.00 USD | |
| 07 Jun 2022 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 30,022 | 0.00 USD | deriv |
| 19 May 2022 | PURCHASE | HYPERION DEFI, INC. | 10,000 | 2.20 USD | |
| 17 Nov 2021 | GRANT_AWARD | HYPERION DEFI, INC. | 6,963 | 0.00 USD | |
| 17 Nov 2021 | GRANT_AWARD | HYPERION DEFI, INC. | 9,653 | 0.00 USD | deriv |
| 13 Sept 2021 | SALE | BIOCRYST PHARMACEUTICALS INC | 6,000 | 15.35 USD | |
| 13 Sept 2021 | EXERCISE | BIOCRYST PHARMACEUTICALS INC | 15,000 | 3.22 USD | |
| 13 Sept 2021 | EXERCISE | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 11 Jun 2021 | PURCHASE | HYPERION DEFI, INC. | 2,000 | 5.38 USD | first after silence |
| 15 Jun 2021 | PURCHASE | HYPERION DEFI, INC. | 2,000 | 5.41 USD | |
| 14 Jun 2021 | PURCHASE | HYPERION DEFI, INC. | 2,000 | 5.47 USD | |
| 25 May 2021 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 11 Sept 2020 | GRANT_AWARD | HYPERION DEFI, INC. | 7,288 | 0.00 USD | |
| 11 Sept 2020 | GRANT_AWARD | HYPERION DEFI, INC. | 9,820 | 0.00 USD | deriv |
| 12 May 2020 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |
| 18 Nov 2019 | PURCHASE | BIOCRYST PHARMACEUTICALS INC | 5,000 | 1.45 USD | first after silence |
| 16 Aug 2019 | GRANT_AWARD | HYPERION DEFI, INC. | 8,038 | 0.00 USD | |
| 16 Aug 2019 | GRANT_AWARD | HYPERION DEFI, INC. | 9,057 | 0.00 USD | deriv |
| 29 May 2019 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 30,000 | 0.00 USD | deriv |
5 purchases reported after at least 12 months of silence — most recent on 11 Jun 2021.